Mable Therapy, a digital health platform for children’s speech and language therapy and counselling services, has secured £3.1 million in Series A investment from Gresham House Ventures.
The funding is set to help Mable expand its technology offering including the development of an intra-therapy app and school screening tools to support educators in assessing students’ mental health and speech needs.
Through its online platform, Mable provides access to a nationwide network of therapists who can deliver one-to-one sessions for children aged four to eight, with focus on remote use of games, activities and interactive resources. In the last year, Mable highlights that it has delivered over 22,000 hours of therapy to over 3,000 children.
Part of the investment has seen Gresham House Ventures, a growth equity investor specialising in software and digital businesses, support the appointment of Oli White as Mable’s CEO, with Mable co-founder and clinical director Martha Currie noting that White’s “expertise will be instrumental as we continue to enhance and expand our service beyond the UK.”
Gresham House Ventures’ associate director Benjamin Faulkner comments: “Mable’s technology transforms the lives of children in their crucial early stages of development. There is significant growth potential for Mable within the wider education and health sectors where its technology offering can drive meaningful efficiencies for public service providers.”
Earlier this year, we looked at the development of a speech analysis app designed to diagnose depression. The AI-based technology created by specialists from Budapest University of Technology and Economics (BME) and Semmelweis University, is hoped to speed up screening for the mental health disorder by recognising biomarkers in users speech.
Last year, Birmingham Community Healthcare NHS FT service for children’s speech and language therapy (SALT) released a set of videos to assist clinicians, parents and carers in supporting children’s communication development. The trust added that the provision of video and telephone consultations are part of SALT services “moves towards being a digital-first organisation.”
Looking at other large-scale investments in technology, UK Research and Innovation (UKRI) announced a £36.5 million investment in healthcare technology last month, with £20 million to develop test treatments and tools using advancements in quantum, robot technology and imaging.
